GKOS (Glaukos) Shiller PE Ratio: (As of Aug. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GKOS Glaukos Corp GKOS
78 GF Score
Price $178.33
GF Value $147.78
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Glaukos Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Glaukos  (NYSE:GKOS) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Glaukos Shiller PE Ratio Related Terms


Glaukos Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Glaukos's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Glaukos Shiller PE Ratio Chart

Glaukos Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Glaukos Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GKOS vs BRKR, BIO, GMED: Shiller PE Ratio Comparison

For the Medical Devices subindustry, Glaukos's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glaukos Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Glaukos's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Glaukos's Shiller PE Ratio falls into.


GKOS
78GF Score
Glaukos Corp GKOS
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Glaukos Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Glaukos's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Glaukos's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.31/333.9520*333.9520
=-0.310

Current CPI (Jun. 2026) = 333.9520.

Glaukos Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 0.030 241.428 0.041
201612 0.004 241.432 0.006
201703 0.020 243.801 0.027
201706 -0.100 244.955 -0.136
201709 0.040 246.819 0.054
201712 0.030 246.524 0.041
201803 -0.080 249.554 -0.107
201806 -0.150 251.989 -0.199
201809 -0.190 252.439 -0.251
201812 0.040 251.233 0.053
201903 -0.040 254.202 -0.053
201906 -0.170 256.143 -0.222
201909 -0.370 256.759 -0.481
201912 0.840 256.974 1.092
202003 -1.240 258.115 -1.604
202006 -0.900 257.797 -1.166
202009 -0.350 260.280 -0.449
202012 -0.240 260.474 -0.308
202103 -0.360 264.877 -0.454
202106 -0.380 271.696 -0.467
202109 0.130 274.310 0.158
202112 -0.470 278.802 -0.563
202203 0.110 287.504 0.128
202206 -0.960 296.311 -1.082
202209 -0.580 296.808 -0.653
202212 -0.660 296.797 -0.743
202303 -0.720 301.836 -0.797
202306 -0.680 305.109 -0.744
202309 -0.630 307.789 -0.684
202312 -0.750 306.746 -0.817
202403 -0.820 312.332 -0.877
202406 -1.000 314.175 -1.063
202409 -0.390 315.301 -0.413
202412 -0.600 315.605 -0.635
202503 -0.320 319.799 -0.334
202506 -0.340 322.561 -0.352
202509 -0.280 324.800 -0.288
202512 -2.320 324.054 -2.391
202603 -0.340 330.213 -0.344
202606 -0.310 333.952 -0.310

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Glaukos (GKOS) Overvalued in 2026?

Based on GuruFocus' analysis, Glaukos stock appears to be overvalued. The current stock price of $178.33 is trading 20.7% above its estimated GF Value™ of $147.78. GuruFocus considers Glaukos to be Modestly Overvalued.

Key valuation signals for GKOS:

  • Shiller PE Ratio:
  • GF Value™: $147.78 vs. price of $178.33 (20.7% above fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the GKOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Glaukos Business Description

Other Exchanges 6GJ:Germany
Address One Glaukos Way, Aliso Viejo, CA, USA, 92656
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
78GF Score

Get the complete analysis for GKOS

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$178.33
Price
$147.78
GF Value